Clinical Trial Update: A Study of Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 study of Epacadostat in combination with Pembrolizumab in patients with metastatic and/or locally advanced sarcoma has results posted as of May 2, 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Epacadostat (epacadostat)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-02